UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II

FEBS letters, 2012-04, Vol.586 (8), p.1093-1100

2012

Volltextzugriff (PDF)

Benefits and burden of the maternally-mediated immunological imprinting

Autoimmunity reviews, 2009-03, Vol.8 (5), p.394-399

2009

Volltextzugriff (PDF)

Toll-like receptors on the fork roads between innate and adaptive immunity

Human immunology, 2011-12, Vol.72 (12), p.1188-1193

2011

Volltextzugriff (PDF)

A Disintegrin and Metalloprotease (ADAM) 10 and ADAM17 Are Major Sheddases of T Cell Immunoglobulin and Mucin Domain 3 (Tim-3)

The Journal of biological chemistry, 2013-11, Vol.288 (48), p.34529-34544

2013

Volltextzugriff (PDF)

Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain

Biochemical and biophysical research communications, 2011-11, Vol.415 (2), p.330-336

2011

Volltextzugriff (PDF)

Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine

Biochimica et biophysica acta, 2014-02, Vol.1843 (2), p.275-287

2014

Volltextzugriff (PDF)

Alternative Intronic Polyadenylation Generates the Interleukin-6 Trans-signaling Inhibitor sgp130-E10

The Journal of biological chemistry, 2014-08, Vol.289 (32), p.22140-22150

2014

Volltextzugriff (PDF)

The proteases HtrA2/Omi and UCH-L1 regulate TNF-induced necroptosis

Cell communication and signaling, 2013-10, Vol.11 (1), p.76-76, Article 76

2013

Volltextzugriff (PDF)

Abstract 1811: AFVT-2101: A FRα × CD16A bispecific innate cell engager for the treatment of solid tumors

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1811-1811

2023

Volltextzugriff (PDF)

A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells

Biochemical journal, 2012-07, Vol.445 (1), p.135-144

2012

Volltextzugriff (PDF)

CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro

Oncotarget, 2016-05, Vol.7 (21), p.30523-30535

2016

Volltextzugriff (PDF)

The disintegrin domain of ADAM17 antagonises fibroblast-carcinoma cell interactions

International journal of oncology, 2013-05, Vol.42 (5), p.1793-1800

2013

Volltextzugriff (PDF)

Development of sandwich ELISA for detection and quantification of human and murine a disintegrin and metalloproteinase17

Journal of immunological methods, 2011-08, Vol.371 (1-2), p.91-96

2011

Volltextzugriff (PDF)

1212 AFVT-2101, an innate immune-cell engager that selectively targets FOLR1 expressing tumor cells to safely harness potent anti-cancer responses

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A1257-A1257

2022

Volltextzugriff (PDF)

Upd3 – An ancestor of the four-helix bundle cytokines

Biochemical and biophysical research communications, 2013-06, Vol.436 (1), p.66-72

2013

Volltextzugriff (PDF)

Clinicopathologic characteristics and patient outcomes of malignant phyllodes tumors: A multi-institution experience

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e23528-e23528

2022

Volltextzugriff (PDF)

Molecular basis of antibody binding to mucin glycopeptides in lung cancer

International journal of oncology, 2016-02, Vol.48 (2), p.587-594

2016

Volltextzugriff (PDF)

Repertoire restriction of immunoglobulin DH gene segments impairs T cell regulation of a thymus-dependent immune response (62.7)

The Journal of immunology (1950), 2011-04, Vol.186 (1_Supplement), p.62-62.7

2011

Volltextzugriff (PDF)

ADAM17-overexpressing breast cancer cells selectively targeted by antibody–toxin conjugates

Cancer Immunology, Immunotherapy, 2013-03, Vol.62 (3), p.411-421

2013

Volltextzugriff (PDF)

Immunoglobulin class switching appears to be regulated by B‐cell antigen receptor‐specific T‐cell action

European journal of immunology, 2012-04, Vol.42 (4), p.1016-1029

2012

Volltextzugriff (PDF)

Class switch recombination appears to be regulated by BCR/idiotype-specific T cell action (62.10)

The Journal of immunology (1950), 2011-04, Vol.186 (1_Supplement), p.62-62.10

2011

Volltextzugriff (PDF)

Clonal Progression during the T Cell-Dependent B Cell Antibody Response Depends on the Immunoglobulin DH Gene Segment Repertoire

Frontiers in immunology, 2014, Vol.5, p.385-385

2014

Volltextzugriff (PDF)

Thymus-independent type 2 antigen induces a long-term IgG-related network memory

Molecular immunology, 2008-05, Vol.45 (10), p.2847-2860

2008

Volltextzugriff (PDF)

The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective

Surgical innovation, 2018-04, Vol.25 (2), p.149-157

2018

Volltextzugriff (PDF)

New L-fuzzy fixed point techniques for studying integral inclusions

Journal of inequalities and applications, 2024-06, Vol.2024 (1), p.83-17

2024

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(39)
Tagungsberichte
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II

Benefits and burden of the maternally-mediated immunological imprinting

Toll-like receptors on the fork roads between innate and adaptive immunity

A Disintegrin and Metalloprotease (ADAM) 10 and ADAM17 Are Major Sheddases of T Cell Immunoglobulin and Mucin Domain 3 (Tim-3)

Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain

Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine

Alternative Intronic Polyadenylation Generates the Interleukin-6 Trans-signaling Inhibitor sgp130-E10

The proteases HtrA2/Omi and UCH-L1 regulate TNF-induced necroptosis

Abstract 1811: AFVT-2101: A FRα × CD16A bispecific innate cell engager for the treatment of solid tumors

A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells

CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro

The disintegrin domain of ADAM17 antagonises fibroblast-carcinoma cell interactions

Development of sandwich ELISA for detection and quantification of human and murine a disintegrin and metalloproteinase17

1212 AFVT-2101, an innate immune-cell engager that selectively targets FOLR1 expressing tumor cells to safely harness potent anti-cancer responses

Upd3 – An ancestor of the four-helix bundle cytokines

Clinicopathologic characteristics and patient outcomes of malignant phyllodes tumors: A multi-institution experience

Molecular basis of antibody binding to mucin glycopeptides in lung cancer

Repertoire restriction of immunoglobulin DH gene segments impairs T cell regulation of a thymus-dependent immune response (62.7)

ADAM17-overexpressing breast cancer cells selectively targeted by antibody–toxin conjugates

Immunoglobulin class switching appears to be regulated by B‐cell antigen receptor‐specific T‐cell action

Class switch recombination appears to be regulated by BCR/idiotype-specific T cell action (62.10)

Clonal Progression during the T Cell-Dependent B Cell Antibody Response Depends on the Immunoglobulin DH Gene Segment Repertoire

Thymus-independent type 2 antigen induces a long-term IgG-related network memory

The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective

New L-fuzzy fixed point techniques for studying integral inclusions

Suchergebnisse filtern